187 related articles for article (PubMed ID: 24116180)
1. Circulating adipocytokines and chronic kidney disease.
Mills KT; Hamm LL; Alper AB; Miller C; Hudaihed A; Balamuthusamy S; Chen CS; Liu Y; Tarsia J; Rifai N; Kleinpeter M; He J; Chen J
PLoS One; 2013; 8(10):e76902. PubMed ID: 24116180
[TBL] [Abstract][Full Text] [Related]
2. Elevated serum leptin, adiponectin and leptin to adiponectin ratio is associated with chronic kidney disease in Asian adults.
Lim CC; Teo BW; Tai ES; Lim SC; Chan CM; Sethi S; Wong TY; Sabanayagam C
PLoS One; 2015; 10(3):e0122009. PubMed ID: 25793395
[TBL] [Abstract][Full Text] [Related]
3. Adipocytokines in Patients with Chronic Kidney Disease Stage 5.
Yahya RS; Atwa MA; El-Sayed IH; El-Ghanaam DM; Hussein DT; El-Taweel FA
Clin Lab; 2016; 62(1-2):21-30. PubMed ID: 27012030
[TBL] [Abstract][Full Text] [Related]
4. Relationship between glomerular filtration rate and the adipokines adiponectin, resistin and leptin in coronary patients with predominantly normal or mildly impaired renal function.
Risch L; Saely C; Hoefle G; Rein P; Langer P; Gouya G; Marte T; Aczel S; Drexel H
Clin Chim Acta; 2007 Feb; 376(1-2):108-13. PubMed ID: 16956602
[TBL] [Abstract][Full Text] [Related]
5. Adiponectin, leptin, and resistin in patients with aortic stenosis without concomitant atherosclerotic vascular disease.
Kolasa-Trela R; Miszalski-Jamka T; Grudzień G; Wypasek E; Kostkiewicz M
Pol Arch Med Wewn; 2011 Oct; 121(10):352-59. PubMed ID: 21952524
[TBL] [Abstract][Full Text] [Related]
6. Elevated plasma levels of endostatin are associated with chronic kidney disease.
Chen J; Hamm LL; Kleinpeter MA; Husserl F; Khan IE; Chen CS; Liu Y; Mills KT; He C; Rifai N; Simon EE; He J
Am J Nephrol; 2012; 35(4):335-40. PubMed ID: 22456114
[TBL] [Abstract][Full Text] [Related]
7. Circulating Chemerin Is Associated With Carotid Plaque Instability, Whereas Resistin Is Related to Cerebrovascular Symptomatology.
Gasbarrino K; Mantzoros C; Gorgui J; Veinot JP; Lai C; Daskalopoulou SS
Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1670-8. PubMed ID: 27312219
[TBL] [Abstract][Full Text] [Related]
8. Adipocytokines and breast cancer risk.
Hou WK; Xu YX; Yu T; Zhang L; Zhang WW; Fu CL; Sun Y; Wu Q; Chen L
Chin Med J (Engl); 2007 Sep; 120(18):1592-6. PubMed ID: 17908478
[TBL] [Abstract][Full Text] [Related]
9. Is there any interaction of resistin and adiponectin levels with protein-energy wasting among patients with chronic kidney disease.
Kaynar K; Kural BV; Ulusoy S; Cansiz M; Akcan B; Misir N; Yaman S; Kaya N
Hemodial Int; 2014 Jan; 18(1):153-62. PubMed ID: 23919731
[TBL] [Abstract][Full Text] [Related]
10. Association of serum adiponectin concentration with aortic arterial stiffness in chronic kidney disease: from the KNOW-CKD study.
Kim CS; Bae EH; Ma SK; Park SK; Lee JY; Chung W; Lee K; Kim YH; Oh KH; Ahn C; Kim SW;
Clin Exp Nephrol; 2017 Aug; 21(4):608-616. PubMed ID: 27514393
[TBL] [Abstract][Full Text] [Related]
11. Association Between Adipokine Profile, Systemic Inflammation, Muscle and Protein Energy Wasting in Children With Chronic Kidney Disease.
Karava V; Kondou A; Dotis J; Christoforidis A; Taparkou A; Farmaki E; Kollios K; Liakopoulos V; Printza N
J Ren Nutr; 2023 Sep; 33(5):629-638. PubMed ID: 37178774
[TBL] [Abstract][Full Text] [Related]
12. Circulating levels of leptin, adiponectin, resistin, and ghrelin in inflammatory bowel disease.
Karmiris K; Koutroubakis IE; Xidakis C; Polychronaki M; Voudouri T; Kouroumalis EA
Inflamm Bowel Dis; 2006 Feb; 12(2):100-5. PubMed ID: 16432373
[TBL] [Abstract][Full Text] [Related]
13. Obesity indices and adipokines in non-diabetic obese patients with early stages of chronic kidney disease.
Stępień M; Stępień A; Wlazeł RN; Paradowski M; Banach M; Rysz M; Rysz J
Med Sci Monit; 2013 Nov; 19():1063-72. PubMed ID: 24280776
[TBL] [Abstract][Full Text] [Related]
14. Adipocytokines and squamous cell carcinoma of the esophagus.
Nakajima TE; Yamada Y; Hamano T; Furuta K; Oda I; Kato H; Kato K; Hamaguchi T; Shimada Y
J Cancer Res Clin Oncol; 2010 Feb; 136(2):261-6. PubMed ID: 19693538
[TBL] [Abstract][Full Text] [Related]
15. Adipocytokines and the risk of coronary heart disease in healthy middle aged men: the PRIME Study.
Luc G; Empana JP; Morange P; Juhan-Vague I; Arveiler D; Ferrieres J; Amouyel P; Evans A; Kee F; Bingham A; Machez E; Ducimetiere P
Int J Obes (Lond); 2010 Jan; 34(1):118-26. PubMed ID: 19823188
[TBL] [Abstract][Full Text] [Related]
16. Serum adipocytokines are associated with microalbuminuria in patients with type 1 diabetes and incipient chronic complications.
Bulum T; Vučić Lovrenčić M; Tomić M; Vučković-Rebrina S; Roso V; Kolarić B; Vuksan V; Duvnjak L
Diabetes Metab Syndr; 2019; 13(1):496-499. PubMed ID: 30641752
[TBL] [Abstract][Full Text] [Related]
17. Adiponectin is associated with early diabetic kidney disease in adults with type 1 diabetes: A Coronary Artery Calcification in Type 1 Diabetes (CACTI) Study.
Bjornstad P; Pyle L; Kinney GL; Rewers M; Johnson RJ; Maahs DM; Snell-Bergeon JK
J Diabetes Complications; 2017 Feb; 31(2):369-374. PubMed ID: 27368123
[TBL] [Abstract][Full Text] [Related]
18. Serum leptin, resistin, visfatin and adiponectin levels in tumor necrosis factor receptor-associated periodic syndrome (TRAPS).
Cantarini L; Obici L; Simonini G; Cimaz R; Bacarelli MR; Merlini G; Vitale A; Lucherini OM; Brizi MG; Galeazzi M; Fioravanti A
Clin Exp Rheumatol; 2012; 30(3 Suppl 72):S108-14. PubMed ID: 22935190
[TBL] [Abstract][Full Text] [Related]
19. Plasma adiponectin concentration has an inverse and a non linear association with estimated glomerular filtration rate in patients with K/DOQI 3 - 5 chronic kidney disease.
Nanayakkara PW; Le Poole CY; Fouque D; van Guldener C; Stehouwer CD; Smulders YM; van Ittersum FJ; Siegert CE; Drai J; Kostense PJ; ter Wee PM
Clin Nephrol; 2009 Jul; 72(1):21-30. PubMed ID: 19640384
[TBL] [Abstract][Full Text] [Related]
20. Plasma adiponectin, visfatin, leptin, and resistin levels and the onset of colonic polyps in patients with prediabetes.
Deng L; Zhao X; Chen M; Ji H; Zhang Q; Chen R; Wang Y
BMC Endocr Disord; 2020 May; 20(1):63. PubMed ID: 32393372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
